The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes among patients (pts) treated with gemcitabine (GEM)-based therapy post-FOLFIRINOX (FFOX) failure in advanced pancreatic cancer (APC).
 
Erica S Tsang
No Relationships to Disclose
 
Jennifer L. Spratlin
Honoraria - Celgene; Lilly/ImClone; Sanofi
Consulting or Advisory Role - Astellas Pharma; Celgene; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
Research Funding - Sanofi
Travel, Accommodations, Expenses - Astellas Pharma
 
Winson Y. Cheung
No Relationships to Disclose
 
Christina Kim
No Relationships to Disclose
 
Shiying Kong
No Relationships to Disclose
 
Yuan Xu
No Relationships to Disclose
 
Sharlene Gill
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Lilly; Shire; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Celgene